| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/26/2011 | US7932370 Fragments of a plant genome; controlling the expression of a gene; tools for genetic mapping; recognizing or isolating identical or related DNA fragments; identification of a particular individual organism; clustering of a group of organisms with a common trait |
| 04/26/2011 | US7932369 Diagnostic test for vitamin B12 |
| 04/26/2011 | US7932367 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 04/26/2011 | US7932364 Extended half life; reduced clearance and immunogenicity; industrial scale production; cells, expression cassettes |
| 04/26/2011 | US7932363 Antibody that binds human eosinophil-derived basic protein |
| 04/26/2011 | US7932360 Recombinant production of mixtures of antibodies |
| 04/26/2011 | US7932358 Antibodies to JTT-1 protein and cells secreting such antibodies |
| 04/26/2011 | US7932357 for drug screening compunds that affect inappropriate regulation, development, or physiology of antigen presenting cells |
| 04/26/2011 | US7932353 Chimeric polypeptide comprising collagen sequences for use as constituents of medicines and cosmetics |
| 04/26/2011 | US7932352 Semaphorin genes (I) |
| 04/26/2011 | US7932351 Soluble kinase receptor for use in identifying modulators to treat and prevent cell proliferative, respiratory, kidney and liver disorders |
| 04/26/2011 | US7932350 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 04/26/2011 | US7932234 Bispecific oligonucleotide for the treatment of CNS malignancies |
| 04/26/2011 | US7932088 High efficiency transformation of Plasmodium falciparum by the lepidopteran transposon, piggyBac |
| 04/26/2011 | US7932087 Transfecting with expression vector under control of murine cytomegalo virus promoter; glutamine synthetase and immunoglobulin gene |
| 04/26/2011 | US7932084 Nutrient broth for use in propagation of progenitor cells; tissue engineering and repair; regenerative medicine |
| 04/26/2011 | US7932083 Ferrodoxins; hydroxylases; self-replicating plasmid |
| 04/26/2011 | US7932072 Perhydrolase providing improved peracid stability |
| 04/26/2011 | US7932071 Thermostable ribonuclease H from Archaeoglobus profundus |
| 04/26/2011 | US7932070 An enzyme mixture containing a first enzyme with DNA polymerase activity and second enzyme containing a 3', 5' exonuclease activity and a reduced DNA polymerization activity |
| 04/26/2011 | US7932067 Detection, isolation and uses of renalase (monoamine oxidase C) |
| 04/26/2011 | US7932066 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 04/26/2011 | US7932062 DNA construct comprising transcriptional terminator sequences for use in enhanced generation of double stranded RNA sequences; improving exogenous gene expression |
| 04/26/2011 | US7932058 Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays |
| 04/26/2011 | US7932056 Crustaceans as production systems for therapeutic proteins |
| 04/26/2011 | US7932030 System for pulling out regulatory elements using yeast |
| 04/26/2011 | US7932022 Dual-labeled molecular constructs for detection of biochemical reactions |
| 04/26/2011 | US7931907 Hepatitis B virus DNA polymerase and surface antigen variants and methods of using same |
| 04/26/2011 | US7931901 T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof |
| 04/26/2011 | US7931897 Therapeutic agent for hematopoietic tumors |
| 04/26/2011 | US7931895 Monoclonal antibodies with enhanced ADCC function |
| 04/26/2011 | US7931893 A pseudotyped feline immunodeficiency virus virion; transfection; expression vectors packaged in packaging cells to generate high titer recombinant virus stocks; gene therapy |
| 04/26/2011 | CA2501984C Erythropoietin receptor binding antibodies |
| 04/26/2011 | CA2488414C Primary cultured adipocytes for gene therapy |
| 04/26/2011 | CA2477698C Rna detection enzymes |
| 04/26/2011 | CA2462932C Method for the detection of cytosine methylations in immobilized dna samples |
| 04/26/2011 | CA2446619C Permeation enhancers |
| 04/26/2011 | CA2446112C A method for regulating immune function in primates using the foxp3 protein |
| 04/26/2011 | CA2420231C Antibodies to human il-1.beta. |
| 04/26/2011 | CA2416572C Bispecific antibody for target cell-specific stimulation of the apo-1 cell surface receptor |
| 04/26/2011 | CA2415397C Use of strains of parapoxvirus ovis for producing antiviral medicaments and medicaments against cancer |
| 04/26/2011 | CA2379115C Dna recombination in eukaryotic cells by the bacteriophage phic31 recombination system |
| 04/26/2011 | CA2370122C Rapid and efficient capture of dna from sample without using cell lysing reagent |
| 04/26/2011 | CA2365259C Banana and melon promoters for expression of transgenes in plants |
| 04/26/2011 | CA2351274C Isolated cocoon silk protein from simulium vittatum and nucleic acids encoding such protein |
| 04/26/2011 | CA2298934C Vectors derived from antibodies for transferring substances into cells |
| 04/26/2011 | CA2295570C Enzymes mixture |
| 04/26/2011 | CA2288526C Seamless capsule for synthesizing biopolymer and method for producing the same |
| 04/26/2011 | CA2271234C Animal models of human prostate cancer progression |
| 04/26/2011 | CA2264012C Compositions and methods for polynucleotide delivery |
| 04/26/2011 | CA2215394C Il-17 receptor |
| 04/26/2011 | CA2201482C Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/21/2011 | WO2011047324A1 Recombinant modified vaccinia ankara (mva) vaccinia virus containing restructured insertion sites |
| 04/21/2011 | WO2011047316A1 Nucleic acid sequences encoding expandable hiv mosaic proteins |
| 04/21/2011 | WO2011047301A1 Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity |
| 04/21/2011 | WO2011047294A1 Therapeuting compositions comprising an rnai agent and a neurotrophic factor and methods of use thereof |
| 04/21/2011 | WO2011047274A1 Conjugative plasmids from clostridium botulinum and methods of use thereof |
| 04/21/2011 | WO2011047269A2 Elongator proteins and use thereof as dna demethylases |
| 04/21/2011 | WO2011047267A1 Chimeric fibroblast growth factors with altered receptor specificity |
| 04/21/2011 | WO2011047262A2 Dual variable domain immunoglobulins and uses thereof |
| 04/21/2011 | WO2011047256A1 Compositions and methods for the treatment of drug-induced hand-foot syndrome |
| 04/21/2011 | WO2011047233A1 Heating, shaking, and magnetizing apparatus and method of operating the same |
| 04/21/2011 | WO2011047191A1 Rice cultivar cl181-ar |
| 04/21/2011 | WO2011047147A1 Microrna mirna-31 as a therapeutic approach for the treatment of cancer |
| 04/21/2011 | WO2011047044A2 A miniaturized electroporation-ready microwell array for high-throughput genomic screening |
| 04/21/2011 | WO2011047031A2 Eliciting immune responses using recombinant mva viruses expressing hiv env, gag and pol anitgens |
| 04/21/2011 | WO2011046996A2 Consensus sequence for influenza a virus |
| 04/21/2011 | WO2011046972A2 Compositions and methods for suppressing primer interactions |
| 04/21/2011 | WO2011046934A1 Methods and compositions for improved delivery, expression or activity of rna interference agents |
| 04/21/2011 | WO2011046786A2 Use of dendrimer nanotechnology for delivery of biomolecules into plant cells |
| 04/21/2011 | WO2011046772A1 Drought tolerant plants and related constructs and methods involving genes encoding self-incompatibility protein related polypeptides |
| 04/21/2011 | WO2011046757A2 Accelerating thrombus resolution through augmentation of p53 activity |
| 04/21/2011 | WO2011046635A1 Differentially methylated regions of reprogrammed induced pluripotent stem cells, method and compositions thereof |
| 04/21/2011 | WO2011046623A2 Hiv-1 antibodies |
| 04/21/2011 | WO2011046520A1 Polypeptide material with adjustable pore properties |
| 04/21/2011 | WO2011046519A1 Polypeptide material composed of elastin-like segments and coiled coil segments |
| 04/21/2011 | WO2011046515A1 Antiproliferative agent |
| 04/21/2011 | WO2011046382A2 Nrf2 inhibitors and use thereof |
| 04/21/2011 | WO2011046249A1 Aspergillus non-inherited genetic variant having enhanced protease activity, and a production method for a natural flavour enhancer employing the same |
| 04/21/2011 | WO2011046221A1 INTERFERON-α MODULATOR |
| 04/21/2011 | WO2011046218A1 Hansenula polymorpha capable of producing antibody, process for production of antibody utilizing same, and antibody produced from same |
| 04/21/2011 | WO2011046214A1 Peptide binding to methylated dna |
| 04/21/2011 | WO2011046202A1 Gene controlling flowering habit/cleistogamy in plants, and use thereof |
| 04/21/2011 | WO2011046193A1 Aptamer capable of binding to viral hemorrhagic septicemia virus |
| 04/21/2011 | WO2011046189A1 Model cells of neurodegenerative disease, process for production of same, and use of same |
| 04/21/2011 | WO2011046177A1 Signal peptide contained in mannose specific lectine precursor, nucleic acid to code for said signal peptide, and use thereof |
| 04/21/2011 | WO2011046160A1 Method for screening of substance capable of preventing virus infection, and agent for preventing virus infection |
| 04/21/2011 | WO2011046097A1 Method for manufacturing igg antibodies for a t-cell-independent antigen, genetically modified silkworm that produces igg antibodies for a t-cell-independent antigen, and manufacturing method therefor |
| 04/21/2011 | WO2011045796A1 Compositions for controlling varroa mites in bees |
| 04/21/2011 | WO2011045765A1 TEMPORALLY PATTERNED OVEREXPRESSION OF Foxg1 AND Emx2 TRANSCRIPTION FACTOR GENES IN NEURAL PRECURSORS FOR BRAIN TISSUE REPAIR |
| 04/21/2011 | WO2011045629A1 Lipid acyltransferase proteins and methods of making them |
| 04/21/2011 | WO2011045612A1 Mycobacterial vaccines |
| 04/21/2011 | WO2011045573A2 Staphylococcal antigens |
| 04/21/2011 | WO2011045381A1 Process for adenovirus purification from high cell density cultures |
| 04/21/2011 | WO2011045378A1 Method for the purification of adenovirus particles |
| 04/21/2011 | WO2011045374A1 Model-guided random assembly pcr for the synthesis of eukaryotic promoters |
| 04/21/2011 | WO2011045333A1 Method to control spider mites |
| 04/21/2011 | WO2011045316A1 Protein synthesis via click chemistry |
| 04/21/2011 | WO2011044701A1 Inhibitors of phosphatase and tensin homolog (pten) compositions, uses and methods |
| 04/21/2011 | WO2011044698A1 Multi epitope vaccine for poultry |